Angelini Pharma acquires Arvelle Therapeutics for $960 million
Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
XCOPRI
FDA approves new treatment for adults with partial-onset seizures
The safety and efficacy of XCOPRI to treat partial-onset seizures was established in two randomized, double-blind,…